Global Veterinary Vaccines Market Size USD 14.74 Billion in 2032 | Emergen Research


Global Veterinary Vaccines Market Sees Strong Growth Driven by Rising Pet Ownership and Zoonotic Disease Concerns

Vancouver, Nov. 08, 2023 (GLOBE NEWSWIRE) — The global veterinary vaccines market size was USD 8.20 Billion in 2022 and is expected to register a revenue CAGR of 6.0% during the forecast period. This growth is attributed to several key factors, including the increasing adoption of pets, a rising incidence of zoonotic diseases, and growing demand for animal protein. In addition, government initiatives and responses to the COVID-19 pandemic have also contributed to the market’s upward trajectory.

Pet Adoption Drives Market Growth


One of the driving forces behind the market’s growth is the increasing adoption of pets worldwide. According to the American Society for the Prevention of Cruelty to Animals, millions of dogs, cats, and other animals end up in shelters each year, and rising pet adoption rates are boosting the demand for veterinary vaccines. Approximately 85 million families own pets, with a significant percentage of dogs and cats adopted from shelters each year, highlighting the importance of vaccination in these animals.

Zoonotic Diseases Fuel Demand

The rise in zoonotic diseases, which can transfer from animals to humans, has contributed to the growing demand for veterinary vaccines. Zoonotic infections account for a significant portion of new infectious diseases in humans, and their impact on public health is substantial. These diseases pose a risk to individuals through various means, including direct contact, food, and the environment. The emergence of new zoonotic diseases is a global public health concern.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @

Government Initiatives Boost Development

Government initiatives aimed at developing veterinary vaccines, such as those targeting tuberculosis, have further driven market growth. For example, the United Kingdom permitted field trials for bovine tuberculosis (bTB) cattle vaccination, while the United States invested in vaccines for diseases like foot-and-mouth disease. These initiatives underscore the importance of vaccine development for animal health and public safety.

COVID-19 and Animal Vaccination

The COVID-19 pandemic has also played a significant role in the market’s growth. Research and development efforts have led to the creation of coronavirus vaccines for animals, including cats, dogs, poultry, and cattle. Companies are investing in developing veterinary vaccines to combat COVID-19 infections in animals, contributing to the market’s expansion.

Challenges and Restraints

Despite the market’s growth, it faces challenges such as common side effects associated with vaccinations, including swelling at the injection site and mild fever. Additionally, high production costs and the need for adjuvants make veterinary vaccines relatively expensive to manufacture.

Latest Trends in Veterinary Vaccines

Several trends are shaping the veterinary vaccines market, including the development of recombinant vaccines, advances in genomics and proteomics, the use of DNA vaccines, and the development of adjuvants in vaccine technology. The focus on diseases like Peste Des Petits Ruminants (PPR) and the use of plant-based vaccines are also gaining momentum.

Regional Insights

North America currently leads the market, with an extensive portfolio of vaccines and mergers and acquisitions driving growth. The Asia Pacific region is seeing steady growth due to investments by key market players and increased product availability. In Europe, research and development activities and a rising incidence of zoonotic diseases, such as Rabies, are contributing to significant market growth.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @

Scope of Research

Report Details Outcome
Market size in 2022 USD 8.20 Billion
CAGR (2023–2032) 6.0%
Revenue forecast to 2032 USD 14.74 Billion
Base year for estimation 2022
Historical data 2019–2021
Forecast period 2023–2032
Quantitative units Revenue in USD Billion and CAGR in % from 2023 to 2032
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Type, disease type, animal type, administration route, technology, and region.
Regional scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country scope U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, Rest of MEA
Key companies profiled Indian Immunologicals Ltd., Merck & Co., Inc., Ceva., Zoetis,

Eli Lilly and Company, Boehringer Ingelheim International GmbH., Phibro Animal Health Corporation., Neogen Corporation., Brilliant Bio Pharma, Elanco, Norbrook,

Heska Corporation, Vetoquinol, IDEXX Laboratories, Inc.,, CHINA ANIMAL HUSBANDRY GROUP,

HIPRA, Intas Pharmaceuticals Ltd., Endovac Animal Health.,

Biogénesis Bagó

Customization scope 10 hours of free customization and expert consultation

Direct Order Can Be Placed Through This Link [Exclusive Copy] @

Major Companies and Competitive Landscape

The global veterinary vaccines market is fragmented with large and medium-sized market players accounting for the majority of revenue. Major players are deploying various strategies, entering into mergers and acquisitions, strategic agreements and contracts, developing, testing, and introducing more effective in the market. Some major players included in the market report are:

  • Indian Immunologicals Ltd.
  • Merck & Co., Inc.
  • Ceva.
  • Zoetis
  • Eli Lilly and Company
  • Boehringer Ingelheim International GmbH.
  • Phibro Animal Health Corporation.
  • Neogen Corporation.
  • Brilliant Bio Pharma
  • Elanco
  • Norbrook
  • Heska Corporation
  • Vetoquinol
  • IDEXX Laboratories, Inc.
  • Intas Pharmaceuticals Ltd.
  • Endovac Animal Health.
  • Biogénesis Bagó

Strategic Development

4 January 2023 Dalan Animal Health, Inc. (‘Dalan’), a biotech business pioneering insect health, reported that the United States Department of Agriculture (USDA) has awarded a conditional license for honeybee immunization against American Foulbrood disease due to Paenibacillus larvae.

8 February 2022 Merck Animal Health, known as MSD Animal Health outside the United States and Canada, is a division of Merck & Co., Inc., USA, and has announced the commercial availability of the CIRCUMVENT CML vaccine as part of its swine product line. The Department of Agriculture (USDA) granted the business a license for the vaccine in the United States in 2022.

29 June 2020 Merck Animal Health, a company of Merck & Co., Inc., Kenilworth, N.J., USA, announced a USD 100 million investment in facility development and upgrade initiatives at its DeSoto, Kansas production location. The site’s investments include a technological extension of the vaccine production plant, as well as an additional USD 66 million investment that will permit additional upgrade capabilities to be realized over the next years.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@

For the purpose of this report, Emergen Research has segmented the global veterinary vaccines market on the basis of type, disease type, animal type, administration route, technology, and region:

  • Type Outlook (Revenue, USD Billion; 2019–2032)
    • Porcine Vaccines
    • Livestock Vaccines
        • Bovine Vaccines
        • Small Ruminant Vaccines
    • Poultry Vaccines
    • Companion animal vaccines
      • Feline vaccines
      • Canine vaccines
    • Other Animal Vaccines
  • Disease Type Outlook (Revenue, USD Billion; 2019–2032)
    • Avian Influenza
    • Rabies coccidiosis
    • Brucellosis
    • Canine distemper
    • Swine pneumonia
  • Animal Type Outlook (Revenue, USD Billion; 2019–2032)
    • Livestock
      • Poultry
      • Cattle
      • Others (horses, goats, camels, and others)
    • Companion
      • Cats
      • Dogs
    • Aquaculture
  • Administration Route Outlook (Revenue, USD Billion; 2019–2032)
    • Oral
    • Injection
    • Spray
  • Technology Outlook (Revenue, USD Billion; 2019–2032)
    • Live attenuated vaccine
    • Inactivated vaccine
    • Recombinant vaccine
    • Toxoid vaccines
    • Other vaccines
  • Regional Outlook (Revenue, USD Billion; 2019–2032)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Benelux
      7. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. South Africa
      4. Turkey
      5. Rest of MEA

Curated Reports You Shouldn’t Miss: Dive In Now!

Carrier Screening Market By Medical Conditions (Pulmonary, Hematological and Neurological Disorders, Others), By Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays, Others), By End User (Hospitals, Reference Laboratories, Physician Offices and Clinics, Others) and By Regions Forecasts to 2027

Depression Treatment Market By Drug Type (Antidepressants, Antipsychotics) By Application (Major Depressive Disorder (MDD), Bipolar Disorder), By End-User (Hospitals, NGOs, Mental Health Centers), By Distribution Channel, and By Region, Forecasts to 2027

 Artificial Organs Market By Organ Type (Artificial Kidney, Liver, Heart, Lungs, Pancreas), By Usage (Implantable, Extracorporeal), By Material Type (Silicon, Plastic, Steel), Forecasts to 2027

Bioremediation Market, By Type (In-Situ Bioremediation and Ex-Situ Bioremediation), By Services (Soil, Wastewater, and Oilfield Remediation and Others), By Technology, and By Region Forecast to 2032

Big Data in Healthcare Market By Component (Software, Services), By Deployment (On-Premises, Cloud), By Analytics Type (Predictive Analytics, Descriptive Analytics), By Application (Clinical Analytics, Financial Analytics), By End User (Hospitals and Clinics), and By Region, Forecasts to 2027

Brachytherapy Market By Type, By Application, By End-Users, Forecasts to 2027

3D Bioprinting Market, By Component, By Application (Research Applications, Clinical Applications), By End-use (Research Organizations and Academic Institutes, Biopharmaceutical Companies), By Region Forecast to 2032

 About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Explore Our Japanese Version: Veterinary Vaccines Market

Explore Our Blogs and Insights Section:

Read our Press Release @

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.